当前位置: 首页 >> 检索结果
共有 4733 条符合本次的查询结果, 用时 7.9463685 秒

2921. Biden prioritises health care in State of the Union speech.

作者: Susan Jaffe.
来源: Lancet. 2024年403卷10431期1009页

2922. Fitness to lead: the health of US presidents.

作者: The Lancet.
来源: Lancet. 2024年403卷10431期997页

2923. Congenital toxoplasmosis of the brain caused by infection in late pregnancy.

作者: Simon Dadoun.;Gail J Demmler-Harrison.;Pamela Ketwaroo.;Eumenia C Castro.;Magdalena Sanz Cortes.
来源: Lancet. 2024年403卷10431期1081-1082页

2925. Inflammation, infection, and cardiovascular risk - Authors' reply.

作者: Paul M Ridker.;Deepak L Bhatt.;Steven E Nissen.
来源: Lancet. 2024年403卷10431期1025-1026页

2926. Inflammation, infection, and cardiovascular risk.

作者: Sanjiv Sharma.;Rohan Sharma.
来源: Lancet. 2024年403卷10431期1024-1025页

2927. Inflammation, infection, and cardiovascular risk.

作者: Michel Goldman.;Antoine Bondue.;Elie Cogan.
来源: Lancet. 2024年403卷10431期1023页

2928. Inflammation, infection, and cardiovascular risk.

作者: Mark R Goldstein.;Luca Mascitelli.
来源: Lancet. 2024年403卷10431期1023-1024页

2929. Inflammation, infection, and cardiovascular risk.

作者: Michael Drozd.;Richard Cubbon.
来源: Lancet. 2024年403卷10431期1022-1023页

2930. Inflammation, infection, and cardiovascular risk.

作者: Anil Pareek.;Nitin Chandurkar.;Kumar Naidu.;Vivek Raut.;Ravishankar Akolekar.
来源: Lancet. 2024年403卷10431期1022页

2931. Inflammation, infection, and cardiovascular risk.

作者: Timo E Strandberg.;Petri T Kovanen.;Helena Gylling.
来源: Lancet. 2024年403卷10431期1021页

2932. Inflammation, infection, and cardiovascular risk.

作者: Gen-Min Lin.;Wei-Chun Huang.;Chih-Lu Han.
来源: Lancet. 2024年403卷10431期1021-1022页

2933. Al-Buluk Children's Hospital in Khartoum.

作者: Esra Eltahir.;Khalid Abdelhafiz.;Mai Ali.;Sara Abdelgalil.;Edward Thomas.
来源: Lancet. 2024年403卷10431期1020-1021页

2934. Zoonotic disease vulnerability escalates amid Sudan's armed conflict.

作者: Yassir Adam Shuaib.
来源: Lancet. 2024年403卷10431期1019-1020页

2935. Offline: What have we done to medical students?

作者: Richard Horton.
来源: Lancet. 2024年403卷10431期1008页

2936. Hard truths about under-5 mortality: call for urgent global action.

作者: João Pedro Azevedo.;Anshu Banerjee.;John Wilmoth.;Haishan Fu.;Danzhen You.
来源: Lancet. 2024年404卷10452期506-508页

2937. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort.

作者: Katie Wong.;David Pitcher.;Fiona Braddon.;Lewis Downward.;Retha Steenkamp.;Nicholas Annear.;Jonathan Barratt.;Coralie Bingham.;Constantina Chrysochou.;Richard J Coward.;David Game.;Sian Griffin.;Matt Hall.;Sally Johnson.;Durga Kanigicherla.;Fiona Karet Frankl.;David Kavanagh.;Larissa Kerecuk.;Eamonn R Maher.;Shabbir Moochhala.;Jenny Pinney.;John A Sayer.;Roslyn Simms.;Smeeta Sinha.;Shalabh Srivastava.;Frederick W K Tam.;Andrew Neil Turner.;Stephen B Walsh.;Aoife Waters.;Patricia Wilson.;Edwin Wong.;Christopher Mark Taylor.;Dorothea Nitsch.;Moin Saleem.;Detlef Bockenhauer.;Kate Bramham.;Daniel P Gale.; .
来源: Lancet. 2024年403卷10433期1279-1289页
Individuals with rare kidney diseases account for 5-10% of people with chronic kidney disease, but constitute more than 25% of patients receiving kidney replacement therapy. The National Registry of Rare Kidney Diseases (RaDaR) gathers longitudinal data from patients with these conditions, which we used to study disease progression and outcomes of death and kidney failure.

2938. The impact of rare kidney diseases on kidney failure.

作者: Olalekan Lee Aiyegbusi.;Anthony Fenton.
来源: Lancet. 2024年403卷10433期1211-1213页

2939. Integrating management of treatment toxicity on patient quality of life in real-world cancer clinics.

作者: Susanne Oksbjerg Dalton.;Christoffer Johansen.
来源: Lancet. 2024年403卷10434期1312-1313页

2940. Lung-function trajectories: relevance and implementation in clinical practice.

作者: Erik Melén.;Rosa Faner.;James P Allinson.;Dinh Bui.;Andrew Bush.;Adnan Custovic.;Judith Garcia-Aymerich.;Stefano Guerra.;Robab Breyer-Kohansal.;Jenny Hallberg.;Lies Lahousse.;Fernando D Martinez.;Simon Kebede Merid.;Pippa Powell.;Hilary Pinnock.;Sanja Stanojevic.;Lowie E G W Vanfleteren.;Gang Wang.;Shyamali C Dharmage.;Jadwiga Wedzicha.;Alvar Agusti.; .
来源: Lancet. 2024年403卷10435期1494-1503页
Lung development starts in utero and continues during childhood through to adolescence, reaching its peak in early adulthood. This growth is followed by gradual decline due to physiological lung ageing. Lung-function development can be altered by several host and environmental factors during the life course. As a result, a range of lung-function trajectories exist in the population. Below average trajectories are associated with respiratory, cardiovascular, metabolic, and mental health comorbidities, as well as with premature death. This Review presents progressive research into lung-function trajectories and assists the implementation of this knowledge in clinical practice as an innovative approach to detect poor lung health early, monitor respiratory disease progression, and promote lung health. Specifically, we propose that, similar to paediatric height and weight charts used globally to monitor children's growth, lung-function charts could be used for both children and adults to monitor lung health status across the life course. To achieve this proposal, we introduce our free online Lung Function Tracker tool. Finally, we discuss challenges and opportunities for effective implementation of the trajectory concept at population level and outline an agenda for crucial research needed to support such implementation.
共有 4733 条符合本次的查询结果, 用时 7.9463685 秒